Research analysts at StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a note issued to investors on Tuesday. The firm set a “hold” rating on the software maker’s stock.
Separately, Stephens lifted their target price on Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a research note on Friday, January 31st.
Get Our Latest Analysis on MDRX
Veradigm Trading Down 5.6 %
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Do ETFs Pay Dividends? What You Need to Know
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- How to Invest in Biotech Stocks
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Top Stocks Investing in 5G Technology
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
